Mr. Vasilios Papadopulos, CEO and chairman of the board of MAXI, granted RECARD an interview where he talks about the company’s history and future, analyzing the effects of the pandemic and outlining a perspective on tissue products and market development.
MAXI is a strong company that grew despite the economic crisis that dramatically struck Greece in 2008. How did the company face the pandemics at first, and how does it face it today?
Maxi was founded more than 30 years ago and has meanwhile established a leading position in the market. The milestone year in its history was 1988, with the company foundation firstly as a commercial business and soon after as a manufacturing entity. Over the years – with continuous investments in state-of-the-art equipment – we reached a production capacity of 68.000 tons p.a. of Jumbo Rolls from 2 paper machines with 20 converting lines downstream for producing Rolls and Folded products for the consumer and professional sectors. The dominant market position, strong financial base, the high production efficiencies achieved and, last but not least, the comprehensive product portfolio has enabled MAXI to weather the storm of the financial crisis without detrimental effects. Today, MAXI SA is a leading force in paper production and processing.
Focusing on our customers’ ultimate satisfaction, we continue with the sustainable development of quality products, investing in highly trained human resources besides our prime mechanical equipment.
During the last year and a half, how did the pandemics change the needs of the Greek and international markets on which MAXI operates?
Hygienic Paper demand has proven to be relatively inflexible in developed markets.
Any loss in the away-from-home sector due to lockdowns was compensated by an increase in demand of consumer product demand. Moreover Maxi strive to produce and supply products of the highest quality that meet our customers’ needs maintaining their dedication and trust. This quality market segment has also proven to be resilient during the pandemic.
